Purchase Order 75N92E18P00165

<p>The National Human Genome Research Institute awarded a purchase order to Illumina, Inc. for $9,715.00 on October 19, 2017, with an ultimate completion date of November 18, 2017. Work is performed in North Bethesda, Maryland. The order is firm fixed price with no set-aside. The source does not specify the technical scope of materials or services procured under this purchase order.</p>

<p>The National Human Genome Research Institute awarded a purchase order to Illumina, Inc. valued at $14,425.00 on January 31, 2018, with ultimate completion on February 1, 2019. Work is performed at North Bethesda, Maryland. The order is a firm fixed price commercial acquisition with no set-aside designation. Specific line items and scope details are not provided in the source material.</p>

<p>The National Human Genome Research Institute awarded a purchase order to Illumina, Inc. for $15,314.69 on August 23, 2017, with an ultimate completion date of September 22, 2017. Work is performed in North Bethesda, Maryland. The order covers sequencing reagents and consumables under firm fixed price terms. No set-aside applied.</p>

<p>The National Human Genome Research Institute awarded a firm fixed-price purchase order to Illumina, Inc., valued at $7,560.42, on August 18, 2017. Performance is located in North Bethesda, Maryland, with an ultimate completion date of September 17, 2017. The order procures supplies—consistent with Illumina's standard provision of genetic sequencing and genomic analysis technologies, reagents, or consumables to the federal research community.</p>

<p>The National Human Genome Research Institute issued a $64,614.22 delivery order to Illumina, Inc. on September 13, 2017, for supplies. The order is firm fixed price with an ultimate completion date of October 12, 2017. Place of performance is North Bethesda, MD.</p>

<p>The National Human Genome Research Institute awarded a purchase order to Illumina, Inc. for $22,472.64 on December 18, 2018. Place of performance is Bethesda, Maryland. The order carries firm fixed price terms with an ultimate completion date of December 18, 2018. No set-aside was used. The specific goods or services procured are not identified in the source.</p>

<p>The National Human Genome Research Institute awarded a purchase order to Illumina, Inc. valued at $7,074.60 for firm fixed price on May 1, 2018, with completion by May 31, 2018. Performance occurs in North Bethesda, Maryland. The order procures sequencing reagents and consumables aligned with Illumina's core portfolio of DNA and RNA sequencing products and bioinformatics support.</p>

<p>The National Human Genome Research Institute awarded a purchase order to Illumina, Inc. for $15,314.69 on July 31, 2018, with final completion by August 29, 2018. The order is firm fixed price with no set-aside. Performance occurs in Bethesda, Maryland. The purchase order procures sequencing reagents, consumables, or related bioinformatics products from Illumina's core portfolio of DNA and RNA sequencing supplies and software.</p>

<p>The National Human Genome Research Institute awarded a purchase order to Illumina, Inc. for $8,182.85 on August 15, 2017, with ultimate completion on September 14, 2017. Place of performance is Bethesda, Maryland. The order procures sequencing reagents, consumables, or related products under firm fixed price terms. No set-aside was applied.</p>

<p>The National Human Genome Research Institute issued a delivery order to Illumina, Inc. on August 1, 2017, with a ceiling value of $5,273.81 under a firm fixed-price arrangement.</p> <p>Place of performance is North Bethesda, MD. The order has an ultimate completion date of September 1, 2017. No set-aside was used for this delivery order.</p>